[HTML] frontiersin.org

[HTML][HTML] Immune checkpoint inhibitors in triple negative breast cancer treatment: promising future prospects

R Thomas, G Al-Khadairi, J Decock - Frontiers in oncology, 2021 - frontiersin.org
Immunotherapy has emerged as the fifth pillar of cancer treatment alongside surgery,
radiotherapy, chemotherapy, and targeted therapy. Immune checkpoint inhibitors are the …
被引用次数：143 相关文章

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects

R Thomas, G Al-Khadairi… - Frontiers in oncology, 2021 - pubmed.ncbi.nlm.nih.gov
Immunotherapy has emerged as the fifth pillar of cancer treatment alongside surgery,
radiotherapy, chemotherapy, and targeted therapy. Immune checkpoint inhibitors are the …
[HTML] frontiersin.org

[HTML][HTML] Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects

R Thomas, G Al-Khadairi, J Decock - Frontiers in Oncology, 2021 - frontiersin.org
Immunotherapy has emerged as the fifth pillar of cancer treatment alongside surgery,
radiotherapy, chemotherapy, and targeted therapy. Immune checkpoint inhibitors are the …

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects

R Thomas, G Al-Khadairi, J Decock - Frontiers in Oncology, 2021 - cir.nii.ac.jp
抄録< jats: p> Immunotherapy has emerged as the fifth pillar of cancer treatment alongside
surgery, radiotherapy, chemotherapy, and targeted therapy. Immune checkpoint inhibitors …

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects

R Thomas, G Al-Khadairi, J Decock - Immunotherapy as an …, 2022 - books.google.com
Breast cancer constitutes a major health problem worldwide, accounting for 30% of all
female cancer cases and 15% of female cancer-related deaths (1). Clinically, breast tumors …
[HTML] nih.gov

[HTML][HTML] Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects

R Thomas, G Al-Khadairi, J Decock - Frontiers in Oncology, 2020 - ncbi.nlm.nih.gov
Immunotherapy has emerged as the fifth pillar of cancer treatment alongside surgery,
radiotherapy, chemotherapy, and targeted therapy. Immune checkpoint inhibitors are the …

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects.

R Thomas, G Al-Khadairi, J Decock - Frontiers in Oncology, 2020 - europepmc.org
Immunotherapy has emerged as the fifth pillar of cancer treatment alongside surgery,
radiotherapy, chemotherapy, and targeted therapy. Immune checkpoint inhibitors are the …